New pharmacological strategies in rheumatic diseases

Targeting the pathogenic pathway of chronic inflammation represents an unmet challenge for controlling disease activity, preventing functional disability, and maintaining an adequate quality of life in patients with rheumatic diseases. Abatacept, a novel molecule that inhibits co-stimulation signal,...

Descripción completa

Detalles Bibliográficos
Autores principales: Schiotis, RE, Buzoianu, AD, Mureșanu, DF, Suciu, S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Carol Davila University Press 2016
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5154305/
https://www.ncbi.nlm.nih.gov/pubmed/27974925

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5154305/
https://www.ncbi.nlm.nih.gov/pubmed/27974925

Ejemplares similares